Technical My Tips

🚨Gold prices dropped—here's why 🚨 Gold prices fell below $3,380 per ounce. What's happening here, and why should traders be paying attention? 📉 Key facts 📌Events: Gold prices fell as easing geopolitical tensions reduced the metal's appeal as a safe-haven asset. 📌Background: Last Friday, President Trump announced a meeting with Putin on 15 August to discuss ending the war in Ukraine. This calmed some market fears. However, don't be too quick to count gold out! 📌Possible outcome: Gold losses are likely limited due to ongoing trade concerns and rising expectations of U.S. rate cuts. With lower rates, gold will become more attractive since it doesn't pay interest. Tip for traders If you're trading gold, keep an eye on the Fed's next moves. Rate cuts could send gold prices higher! 📈

The EURUSD pair rebounded above both EMAs, closing above the support level of 1.1600. Recent uncertainty surrounding trade policy and inflation eased the Sep rate cut expectation. Will expectations of a delay in the ECB's rate cut prompt the EURUSD to test 1.1800? #EURUSD #ECB

GBPUSD rose last week amid the BoE’s rate cut and its hawkish tone, which tempered easing expectations. While holding above both EMAs, it tests a bearish trendline, and the pattern of lower swings underscores lingering downside risk. Could GBPUSD break 1.3500 and extend toward 1.3625? #GBPUSD

What’s the company behind the weight-loss drug Mounjaro™ that’s got investors and traders hungry for more? Eli Lilly and Company—often referred to as Lilly—is the pharmaceutical giant behind Mounjaro™ and Zepbound™ (tirzepatide), a weight-loss and diabetes treatment that’s storming the markets. Since early 2020, Lilly’s stock has soared over 300%. When Mounjaro was first approved in May 2022, shares were trading at 284.14 USD. Today, they're hovering near 640.00 USD. According to MarketWatch, Eli Lilly’s stock is down approximately 17% in 2025 (YTD), but the long-term bullish outlook remains strong, driven by the surging demand in the obesity drug market. From a fundamentals perspective, Lilly now holds a 685 billion USD market cap. Over the past 12 months, it has generated 49 billion USD in revenue, with 20 billion USD in operating profit and 11 billion USD in net income. Pharma is feasting on the weight-loss wave. Are you buying, selling,or waiting for the next course?

Here are the important upcoming news events that could affect your trading. Learn more:

With XM Copy Trading, you can pick from over 9000 expert strategies and trade like a pro. 😎 No guesswork. No stress. Choose your expert. Copy their moves. Trade like one. 🤑 Start copy trading with XM now: https://tlt.ink/xmbro #XM #XMCopyTrading #TradeSmart #XMIndia #TradingForBeginners #ForexIndia

Watch Free 🔴 Live Match 🏏 Play Games And Win Real Cash 🤑 Welcome Bonus 500rs Sign Up Now👇 ✔️ Link:http://bit.ly/3zeqJ2L USE PROMO CODE FOR 150% DEPOSIT BONUS ➡️ SMT150 JEET150

📊Join For Free ➡️TLT QUOTEX TRADING channel. Make profit together.📊 Join Now 👇👇👇👇👇👇👇👇👇👇👇   https://t.me/+u5QKtCP9W3kwNTc1

➡️You Can Join Quotex From Link Below 💥 ➡️Start With Free Demo Account & Get 700'000 Demo Balance ✅ ➡️Quotex Link: https://tlt.ink/quotex Use Promo Code ➡️ 50TMT , 50TLT

Open Account In Exness For Forex Trading & P2P Transaction👇 Link: https://tlt.ink/exness

Keep an eye on market news and economic events that may impact your trading strategy. Start Trading:

Happy Raksha Bandhan! May your life be full of light, joy, and endless success. Wishing you a day filled with sweets, love, and sibling banter. May this Rakhi bring you prosperity and peace in all that you do.

From stealing chocolates to guarding secrets, some bonds grow stronger with time. 🤝🤗 Just like the trust our traders place in XM. This Rakshabandhan, help your sibling start their trading journey & earn $200 in the process.🤑 🗓️ Promo valid till August 31. #XM #XMIndia #HappyRakshaBandhan

Spill the tea to earn $200 per friend who joins XM. ☕💸 Here’s how it works: - Share your referral link - Your friend signs up and trades 3 lots on Forex, Gold or Silver - You get $200 in your account There’s no cap, refer as many friends as you want and keep earning. 🤑 🏃‍♂️ Promo valid till August 31! Refer your friend now : #XM #XMIndia #ReferAndEarn #ForexTrading

🍽️ What’s the company behind the weight-loss drug Mounjaro™ that’s got investors and traders hungry for more? Eli Lilly and Company—often referred to as Lilly—is the pharmaceutical giant behind Mounjaro™ and Zepbound™ (tirzepatide), a weight-loss and diabetes treatment that’s storming the markets. Since early 2020, Lilly’s stock has soared over 300%. When Mounjaro was first approved in May 2022, shares were trading at 284.14 USD. Today, they're hovering near 640.00 USD. According to MarketWatch, Eli Lilly’s stock is down approximately 17% in 2025 (YTD), but the long-term bullish outlook remains strong, driven by the surging demand in the obesity drug market. From a fundamentals perspective, Lilly now holds a 685 billion USD market cap. Over the past 12 months, it has generated 49 billion USD in revenue, with 20 billion USD in operating profit and 11 billion USD in net income. 📈📉 Pharma is feasting on the weight-loss wave. Are you buying, selling, or waiting for the next course?